BERENICE is an acronym and stands for "Benznidazol and Triazol REsearch group for Nanomedicine and Innovation on Chagas diseasE". BERENICE is a Collaborative Project which is funded under the European Community's 7th Framework Programme. The project started on the 1st September 2012 and will last for five years.

BERENICE in brief

  • Title: "Benznidazol and Triazol REsearch group for Nanomedicine and Innovation on Chagas diseasE".
  • Call: FP7-HEALTH-2012-INNOVATION-1
  • Acronym: BERENICE
  • EC contribution: € 2.998.217
  • Duration: 60 months
  • Starting date: 01/09/2012
  • Funding scheme: Collaborative Project
  • Contract/Grant agreement number: HEALTH-30593

BERENICE (Benznidazol and Triazol REsearch group for Nanomedicine and Innovation on Chagas diseasE) has been created to obtain a more effective, better tolerated and cheaper formulation of a drug with trypanocidal activity to cure Chagas disease.